Since FA patients display a high risk of childhood acute myeloid leukemia (AML), we stably knocked down FANCA in the AML cell line THP‐1 to assess sensitivity to SIK2 inhibition in a relevant cancer type. This evidence concerns the gene SIK2 and acute myeloid leukemia.